Switzerland· 54959036
Rohypnol 1 mg, Filmtabletten
A flunitrazepam product containing flunitrazepamum, registered in Switzerland by Cheplapharm Schweiz GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Flunitrazepam is registered in 8 of 19 countries.
Countries holding a registration under ATC N05CD03 (flunitrazepam), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 4 of them publish a price we can compare per daily dose
Flunitrazepam · ATC N05CD03
8 / 19 countries
- Belgiumprice
- Finlandprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of flunitrazepam costs, country by country.
Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.
- Switzerland: $0.93 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Flunitrazepam · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.93
The record
At a glance
Swissmedic (Switzerland)- Active substance
- flunitrazepamum
- Manufacturer
- Cheplapharm Schweiz GmbH
- Country
- Switzerland (CH)
- ATC code
- N05CD03
- ATC class
- Flunitrazepam
- Defined daily dose
- 1 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768054959036630 StkCHF 13.45
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
44 interactions on record for flunitrazepam.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flunitrazepam · interactions on record
44 records
44 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Flunitrazepam in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsFlunitrazepam 1 mg Teva, tablettenTeva Nederland B.V.
- NorwayFlunitrazepam tevaTeva B.V.
- BelgiumFlunitrazepam EG 1 mgEG
- GermanyRohypnolCheplapharm Arzneimittel Gmbh
- United KingdomRohypnol 1mg tabletsRoche Products Ltd
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Rohypnol
- Belgium · Flunitrazepam Eg
- Cyprus · Hipnosedon
- Germany · Rohypnol
- Greece · Hipnosedon
- Italy · Roipnol
- Luxembourg · Flunitrazepam Eg
- Netherlands · Flunitrazepam Cf, Flunitrazepam Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7357da3-6169-49c4-b024-89bc29e60c83 GET /v1/drugs/f7357da3-6169-49c4-b024-89bc29e60c83?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "flunitrazepamum 1 mg",
"valid_from": "1986-03-15",
"limitations": null,
"galenic_form": "Filmtabl 1 mg m Farbzusatz",
"therapeutic_area": null,
"sl_inclusion_date": "1986-03-15",
"self_retention_pct": 10
}See everything about flunitrazepam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.